Command Palette

Search for a command to run...

BETA
1720(-0.64%)
1W: -4.88%

Beta Drugs Quarterly Results

Pros & Cons

POSITIVES
  • Consistent revenue growth observed over the last four quarters, indicating strong demand for products.
  • Improved profit margins in the latest quarter, suggesting better cost management and pricing strategies.
  • Strong cash flow generation, which enhances financial stability and supports future investments.
NEGATIVES
  • Declining net profit in the last quarter compared to previous quarters, raising concerns about profitability sustainability.
  • Increased operational costs reported, which could impact margins if not controlled effectively.
  • Inventory levels have risen significantly, indicating potential overproduction or reduced sales efficiency.

Quarterly Results Data (Numbers are in Crore)

FieldTrend
Expenses
-
Operating Profit
-
Other Income
-
Tax
-

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.